SAN JOSE, Calif., April 14, 2025 /PRNewswire/ -- Harmonic (NASDAQ: HLIT) today announced it will release its first quarter ...

Third Harmonic Bio has abandoned plans to take its chronic spontaneous urticaria (CSU) drug into phase 2, instead preparing ...

Shares of Third Harmonic Bio, Inc. (THRD) drew investor attention on Monday after the company announced that its board of ...

The Atlas-backed company plans to liquidate its assets, including an experimental drug for chronic spontaneous urticaria it ...

Third Harmonic Bio (NASDAQ:THRD) will be liquidating the company and selling its remaining assets, the company said on Monday ...

Third Harmonic Bio Inc (NASDAQ:THRD) shares are soaring on Monday after the company announced a plan of liquidation and dissolution.

Shares of Third Harmonic surged on Monday after the company's board approved a liquidation plan that will pay out $5.13 to $5.33 per share. The stock was up 37% at $4.99 in premarket trading. Shares ...

We recently published a list of 20 Small-Cap Stocks Insiders Were Buying in Q1 2025. In this article, we are going to take a ...

Harmonic today announced industry-first innovations to its comprehensive playout-to-delivery solution, empowering ...

Board of Directors has approved plan to liquidate and intends to seek stockholder approval for dissolution of the Company at the Annual Meeting ...

The Nifty Auto Index may well be on the verge of a reversal, with stocks like MRF and Exide Industries lining up as early ...

At the core of the latest updates to Harmonic’s playout-to-delivery solution are powerful loop record and delay line features ...